| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2023 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Merck | 42 | Q3 2023 | 5.7% |
| Newmont Mining | 42 | Q3 2023 | 7.2% |
| Procter & Gamble | 42 | Q3 2023 | 4.9% |
| Intel | 42 | Q3 2023 | 5.0% |
| Johnson & Johnson | 42 | Q3 2023 | 3.7% |
| International Flavors & Fragra | 42 | Q3 2023 | 4.2% |
| Automatic Data Processing | 42 | Q3 2023 | 3.9% |
| Sysco | 42 | Q3 2023 | 4.2% |
| Northern Trust | 42 | Q3 2023 | 4.0% |
| Novartis AG (ADR) | 42 | Q3 2023 | 3.7% |
View WILKINS INVESTMENT COUNSEL INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-09 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-07 |
| 13F-HR | 2023-05-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-10 |
View WILKINS INVESTMENT COUNSEL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.